Litcius/Paper detail

A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial

Susana Banerjee, Mónica Tang, Rachel O’Connell, Katrin Marie Sjoquist, Andrew R. Clamp, David Millan, Steven Nottley, Rosemary Lord, Vinod Mullassery, Marcia Hall, Charlie Gourley, Tony Bonaventura, Jeffrey C. Goh, Peter Sykes, Peter Grant, Orla McNally, Laura E. Crotty Alexander, Caroline Kelly, Karen Carty, Laura Divers, Nathan Bradshaw, Richard J. Edmondson, Michael Friedländer

2021Gynecologic Oncology43 citationsDOI

Topics & Concepts

MedicineAnastrozoleClinical endpointInternal medicineAromatase inhibitorProgression-free survivalOncologyPhases of clinical researchHormonal therapyAdverse effectClinical trialGynecologyAromataseChemotherapyBreast cancerCancerEstrogen and related hormone effectsOvarian cancer diagnosis and treatmentMenopause: Health Impacts and Treatments